M. J. Biopharm Private Limited Imipenem Export Data — India (DGFT 2022–2026)

Name: M. J. Biopharm Private Limited Imipenem Export Records India — #6 Exporter, 9 Shipments, $450.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Imipenem

India Pharmaceutical Trade Intelligence

$33.3M140 Suppliers94 CountriesHS 30049099

ExportsIndia → MEXICO27.2%India → BELGIUM10.0%

ImportsUNITED KINGDOM → India$131.3K UNITED STATES → India$111.3K

#1 Supplier: VENUS REMEDIES

M. J. Biopharm Private Limited — Imipenem Exporter #6 | $678.9K Trade Value | TransData Nexus | TransData Nexus

M. J. Biopharm Private Limited — Imipenem Exporter Profile

Indian Pharmaceutical Exporter · #6 for Imipenem · $678.9K export value · DGFT Verified

M. J. Biopharm Private Limited is the #6 Indian exporter of Imipenem with $678.9K in export value and 9 verified shipments. M. J. Biopharm Private Limited holds a 1.3% market share in Imipenem exports across 2 countries. The company exports 6 pharmaceutical products worth $22.4M across 4 therapeutic categories.

M. J. Biopharm Private Limited — Imipenem Export Profile: Buyers & Destinations

M. J. Biopharm Private Limited Imipenem export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Imipenem?

Country	Value	Shipments	Share
BELGIUM	$2.5M	49	17.1%
MYANMAR	$2.0M	52	14.1%
SAUDI ARABIA	$1.4M	78	9.4%
MOROCCO	$1.4M	27	9.4%

Who Are the Top Buyers of Imipenem from India?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.6M	31
PHARMEDIC SA	ECUADOR	$900.0K	18
M/S. SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$600.0K	12
LABORATORIOS JAYOR S.A. DE C.V.	MEXICO	$400.0K	8
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$350.0K	7
LABORATORIOS JAYOR S A DE C V	MEXICO	$200.0K	4
L J S.A DE CV	MEXICO	$200.0K	4
BANK OF CEYLON	SRI LANKA	$100.0K	2
L J S A D C	MEXICO	$100.0K	2
LABORATORIOS JAYOR, S. A. DE C. V	MEXICO	$100.0K	2

India's Imipenem is purchased by 302 buyers worldwide. The top buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by PHARMEDIC SA and M/S. SUN PHARMACEUTICALS MOROCCO LL.

How Does M. J. Biopharm Private Limited Compare to Nearest Imipenem Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	SUN PHARMACEUTICAL INDUSTRIES LTD	$750.0K	15	8	$50.0K
3	SWISS PARENTERALS LIMITED	$450.0K	9	6	$50.0K
6	M J BIOPHARM PRIVATE LIMITED ★	$450.0K	9	2	$50.0K
7	VEXXA LIFESCIENCES PVT. LTD.	$348.2K	38	3	$9.2K
9	KWALITY PHARMACEUTICALS LIMITED	$324.4K	18	4	$18.0K

M. J. Biopharm Private Limited ranks #6 among 140 Indian Imipenem exporters. Average shipment value of $50.0K compared to the market average of $143.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LTD and SWISS PARENTERALS LIMITED.

Which Indian Ports Ship Imipenem Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	114	14.2%
DELHI AIR	83	10.3%
SAHAR AIR	76	9.5%
SAHAR AIR CARGO ACC (INBOM4)	57	7.1%
NHAVA SHEVA SEA (INNSA1)	37	4.6%
Delhi Air	34	4.2%
DHANNAD ICD	30	3.7%
DHANNAD ICD (INDHA6)	27	3.4%

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Imipenem Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like M. J. Biopharm. Escalating tensions in the Middle East, particularly the Israel-Iran conflict, have disrupted key shipping routes through the Red Sea and the Suez Canal. Major carriers have suspended or rerouted shipments, leading to increased transit times and freight costs. This situation poses significant logistical hurdles for time-sensitive pharmaceutical exports. (livemint.com)

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the U.S. has also implemented policies favoring domestic manufacturing, such as the "Buy American" initiative, which could impact Indian companies' access to this lucrative market. (walterhealthcare.co.in)

In the European Union, stringent regulations like the Falsified Medicines Directive necessitate rigorous compliance from exporters. Indian companies must navigate these complex requirements to maintain market access, emphasizing the need for robust quality assurance systems. (ipa-india.org)

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent guidelines to ensure product safety and efficacy. Indian companies have faced challenges, including increased compliance costs and potential reductions in export volumes due to evolving regulations. (transdatanexus.com)

For M. J. Biopharm, maintaining adherence to these standards is crucial to sustain and expand its export markets. Investments in quality control, staff training, and infrastructure are essential to meet the evolving requirements and to build trust with international partners and regulatory bodies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Imipenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: M. J. Biopharm Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 94+ countries, 302+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Imipenem

Imipenem

M. J. Biopharm Private Limited — Imipenem Exporter Profile

M. J. Biopharm Private Limited — Imipenem Export Profile: Buyers & Destinations

Where Does India Export Imipenem?

Who Are the Top Buyers of Imipenem from India?

What Is India's Total Imipenem Export Value and How Much Does M. J. Biopharm Private Limited Contribute?

What Is the Average Shipment Value for M. J. Biopharm Private Limited's Imipenem Exports?

How Does M. J. Biopharm Private Limited Compare to Other Indian Imipenem Exporters?

Regulatory Requirements: Exporting Imipenem to Key Markets

Mexico — COFEPRIS

How Does M. J. Biopharm Private Limited Compare to Nearest Imipenem Exporters?

Which Indian Ports Ship Imipenem Exports?

What Other Advanced Antibiotics Products Does M. J. Biopharm Private Limited Export?

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Imipenem Exports

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

About M. J. Biopharm Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Imipenem Export Data from M. J. Biopharm Private Limited

Imipenem Stats

Company Overview

Top Products by M. J. Biopharm Private Limited

Related Analysis

Need Detailed Export Data?

Data Source